Ruicheng Hu
33 papers receiving 481 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 253
- Pulmonary and Respiratory Medicine 206
- Cancer Research 120
- Epidemiology 57
- Physiology 54
Countries citing papers authored by Ruicheng Hu
This map shows the geographic impact of Ruicheng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruicheng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruicheng Hu more than expected).
Fields of papers citing papers by Ruicheng Hu
This network shows the impact of papers produced by Ruicheng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruicheng Hu. The network helps show where Ruicheng Hu may publish in the future.
Co-authorship network of co-authors of Ruicheng Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Ruicheng Hu. A scholar is included among the top collaborators of Ruicheng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruicheng Hu. Ruicheng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 38 | |
| 6 | CHOP overexpression sensitizes human non-small cell lung cancer cells to cisplatin treatment by Bcl-2/JNK pathway. | 13 |
| 7 | Effect of Atorvastatin on Lung Apoptosis-Associated Protein Caspase-12 in Chronic Obstructive Pulmonary Disease (COPD) Model Rats | 1 |
| 8 | 16 | |
| 9 | 36 | |
| 10 | 21 | |
| 11 | 15 | |
| 12 | Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells. | 27 |
| 13 | [The expression and possible role of SENP1 in the pulmonary vascular wall of rat during the development of hypoxic pulmonary hypertension]. | 3 |
| 14 | 18 | |
| 15 | 1 | |
| 16 | 36 | |
| 17 | Effects of mitogen activated protein kinase on γ-glutamylcysteine synthase in lung of guinea pigs with bronchial asthma | 1 |
| 18 | 42 | |
| 19 | 18 | |
| 20 | 23 |
About Ruicheng Hu
Ruicheng Hu is a scholar working on Biochemistry, Cancer Research and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 503 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (10 papers), Pulmonary Hypertension Research and Treatments (8 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (120 citations), Pulmonary and Respiratory Medicine (206 citations) and Molecular Biology (253 citations). Ruicheng Hu has collaborated with scholars based in China. Frequent co-authors include Aiguo Dai, Yongliang Jiang, Qifang Li, Li Zhu, Yunrong Chen, Lile Wang, Jingjing Liu, Wenen Liu, Qing Ouyang and Jie Li. Their work appears in journals such as The International Journal of Biochemistry & Cell Biology, Cytokine and Dyes and Pigments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.